Filing Details
- Accession Number:
- 0001140361-21-014994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-29 17:07:38
- Reporting Period:
- 2021-04-27
- Accepted Time:
- 2021-04-29 17:07:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1445499 | Impel Neuropharma Inc | IMPL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1081714 | R Henry Kravis | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1081715 | R George Roberts | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025 | No | No | No | No | |
| 1404912 | Kkr & Co. Inc. | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1472694 | Llp Management Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1472698 | L.p. Partnership Group Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1743754 | Kkr Group Holdings Corp. | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1792665 | L.p. Fund Growth Strategic Healthcare Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1792670 | Kkr Hcsg Gp Llc | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1792766 | L.p. Hcsg Associates Kkr | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No | |
| 1857860 | Kkr Iris Investors Llc | C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 30 Hudson Yards New York NY 10001 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-27 | 2,583,926 | $0.00 | 2,583,926 | No | 4 | C | Indirect | See footnotes |
| Common Stock | Acquisiton | 2021-04-27 | 118,712 | $13.50 | 2,702,638 | No | 4 | J | Indirect | See footnotes |
| Common Stock | Acquisiton | 2021-04-27 | 1,100,000 | $15.00 | 3,802,638 | No | 4 | P | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnotes |
| No | 4 | J | Indirect | See footnotes |
| No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series D Preferred Stock | Disposition | 2021-04-27 | 42,307,448 | $0.00 | 2,583,926 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- Upon the closing of the Issuer's initial public offering, each share of the Issuer's Series D Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-to-16.37332 basis.
- Securities held directly by KKR Iris Investors LLC ("KKR Iris"). KKR Health Care Strategic Growth Fund L.P. is the managing member of KKR Iris. KKR Associates HCSG L.P. is the general partner of KKR Health Care Strategic Growth Fund L.P. KKR HCSG GP LLC is the general partner of KKR Associates HCSG L.P. KKR Group Partnership L.P. is the sole member of KKR HCSG GP LLC. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR & Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP.
- Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.
- Reflects a convertible promissory note in which the outstanding principal amount and accrued interest automatically converted into shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering at 90% of the public offering price.
Billionaire Hedge Funds
